Acetylation site specificities of lysine deacetylase inhibitors in human cells
about
Dynamic Protein Acetylation in Plant-Pathogen InteractionsHistone deacetylases in monocyte/macrophage development, activation and metabolism: refining HDAC targets for inflammatory and infectious diseasesStructural insights into HDAC6 tubulin deacetylation and its selective inhibitionHistone deacetylase 3 (HDAC 3) as emerging drug target in NF-κB-mediated inflammationEpigenetic treatment of pancreatic cancer: is there a therapeutic perspective on the horizon?Profiling technologies for the identification and characterization of small-molecule histone deacetylase inhibitorsA Proteomic Approach to Analyze the Aspirin-mediated Lysine AcetylomeChemoproteomic profiling reveals that cathepsin D off-target activity drives ocular toxicity of β-secretase inhibitorsEvaluation of the Therapeutic Potential of the Novel Isotype Specific HDAC Inhibitor 4SC-202 in Urothelial Carcinoma Cell Lines.Histone Deacetylase 10 Regulates the Cell Cycle G2/M Phase Transition via a Novel Let-7-HMGA2-Cyclin A2 Pathway.From HDACi to KDACi: we need to revisit non-epigenetic pathways affected by inhibiting lysine deacetylases in therapy.Fungal KATs/KDACs: A New Highway to Better Antifungal Drugs?Hallmarks of therapeutic management of the cystic fibrosis functional landscape.Quantitative Analysis of Global Proteome and Lysine Acetylome Reveal the Differential Impacts of VPA and SAHA on HL60 CellsMechanisms and Dynamics of Protein Acetylation in Mitochondria.HDAC8 Inhibition Blocks SMC3 Deacetylation and Delays Cell Cycle Progression without Affecting Cohesin-dependent Transcription in MCF7 Cancer Cells.Histone deacetylase 3 regulates the inflammatory gene expression programme of rheumatoid arthritis fibroblast-like synoviocytesSIRT1-mediated downregulation of p27Kip1 is essential for overcoming contact inhibition of Kaposi's sarcoma-associated herpesvirus transformed cellsPurification of metal-dependent lysine deacetylases with consistently high activity.Histone and Non-Histone Targets of Dietary Deacetylase Inhibitors.The contribution of mass spectrometry-based proteomics to understanding epigenetics.Lysine Deacetylases Exhibit Distinct Changes in Activity Profiles Due to Fluorophore Conjugation of Substrates.Histone deacetylase adaptation in single ventricle heart disease and a young animal model of right ventricular hypertrophy.Interrogating Substrate Selectivity and Composition of Endogenous Histone Deacetylase Complexes with Chemical Probes.Targeting histone deacetylase 8 as a therapeutic approach to cancer and neurodegenerative diseases.HDACs and HDAC Inhibitors in Cancer Development and Therapy.Metabolic control of epigenetics in cancer.KATapulting toward Pluripotency and Cancer.Tenovin-6 inhibits proliferation and survival of diffuse large B-cell lymphoma cells by blocking autophagy.Metabolic regulation of gene expression through histone acylations.The acetyl code in rheumatoid arthritis and other rheumatic diseases.HDAC1 and HDAC2 integrate the expression of p53 mutants in pancreatic cancer.Comparative Mitochondrial-Based Protective Effects of Resveratrol and Nicotinamide in Huntington's Disease Models.KDAC8 substrate specificity quantified by a biologically relevant, label-free deacetylation assay.NFATc1 supports imiquimod-induced skin inflammation by suppressing IL-10 synthesis in B cells.Synthesis and SAR assessment of novel Tubathian analogs in the pursuit of potent and selective HDAC6 inhibitors.Human monocytes downregulate innate response receptors following exposure to the microbial metabolite n-butyrate.Proteome-wide acetylation dynamics in human cellsTenovin-6 impairs autophagy by inhibiting autophagic flux.Targeted Proteomic Analyses of Histone H4 Acetylation Changes Associated with Homologous-Recombination-Deficient High-Grade Serous Ovarian Carcinomas.
P2860
Q26749509-A01D186A-8825-4040-8BA9-18D6B7C8A3CAQ26768497-C5A130AF-7A48-499D-81DB-21365A16FA62Q27721834-7CFA4A46-8A57-4D37-B2EB-F11AAC48F13FQ28076052-3DBC8DCC-8042-4470-B352-88392DA246C1Q28076548-28C683A9-C48A-48BF-A3F2-05B3BFB7A4F4Q28079587-D6801403-6592-4791-A444-DBAD36BA69DEQ28817404-E3701E49-709F-474F-8D1C-AEA9A3289344Q28822108-60416096-19BA-4264-9B98-E3B8B8581D5DQ30489412-15557D58-D8BB-40F8-95DC-1BC0264586E5Q36070032-8961AF66-B674-4E15-9176-5A51A948449EQ36178413-9568E9C2-F737-400D-8E1D-EC51ABBEEF90Q36188969-9874B371-3295-49BD-BE92-6D5662F90C5FQ36279553-2E9969B4-5A13-44D3-82EB-98311F6D471CQ36517161-7E88E840-9793-4012-B2EA-11F897415BECQ36665018-2306526A-5AB8-41CB-BEE3-2FF8F524CD19Q37066442-E2BC71F1-B192-471C-B595-3E108E4D76CCQ37604525-694018DA-D1D8-4B17-91B2-56F1AA2E360BQ37689009-2466C357-2F37-4983-93C2-2FB894BB425EQ38398820-92246EAC-CFD3-4E69-AFE7-431D291FABCAQ38572921-37DFF579-5028-459E-AB14-3733ECC9AAD3Q38647501-AE3E1AE7-3457-476C-BD1B-6237FB26B35CQ38658061-0FC7D5BB-658A-4212-9379-634D6C511F29Q38678462-1D0A9C28-FF48-4EE3-9C07-C20627D34255Q38812013-8A2CD655-0046-482D-82AF-F1B4C58C5AE7Q38826740-6FB9C881-C95C-4D3F-A356-4B1EFD6570C4Q38947405-E5F6CECB-AD61-488D-89A7-11123F3D68C3Q38955875-9599A1E7-739D-4FDB-AA3D-1AE522D96FA1Q38976614-E38753F6-C6BE-4ABC-9787-2C9AC4C22E85Q39001598-86E6A979-053E-4008-97C6-E2164599E4A3Q39031046-D791480A-F0CA-42E3-9FC3-FCF3EED0AD82Q39094945-472F0108-4F38-49E0-8211-2EA39696F9ABQ39307665-66BB6C96-974B-4A78-A383-5394EF5C287DQ39427235-466A50A2-C0B3-44BA-B3CC-ECD40478D6ABQ39719386-BCDC0077-E2E5-43E0-A675-55F9025D46A2Q39738126-9969F6F5-5225-4A45-813C-785A43701067Q40047077-7225E59A-DC06-46D7-A029-6305EBD63BF1Q40145966-9F3D3005-3110-4347-8B26-45C559F11A0EQ41580252-4897BE16-E182-482F-B7FE-176387973EACQ42134620-1FD95D94-3065-4A87-A136-9CB9C19C554DQ42274807-20A15F36-A69C-49A4-AE79-0CFB4A2BAFF4
P2860
Acetylation site specificities of lysine deacetylase inhibitors in human cells
description
2015 nî lūn-bûn
@nan
2015 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մարտին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Acetylation site specificities of lysine deacetylase inhibitors in human cells
@ast
Acetylation site specificities of lysine deacetylase inhibitors in human cells
@en
type
label
Acetylation site specificities of lysine deacetylase inhibitors in human cells
@ast
Acetylation site specificities of lysine deacetylase inhibitors in human cells
@en
prefLabel
Acetylation site specificities of lysine deacetylase inhibitors in human cells
@ast
Acetylation site specificities of lysine deacetylase inhibitors in human cells
@en
P2093
P2860
P50
P3181
P356
P1433
P1476
Acetylation site specificities of lysine deacetylase inhibitors in human cells
@en
P2093
Anna R McCarthy
Chunaram Choudhary
James E Bradner
Jürgen Cox
Matthias Mann
Patrick Matthias
Sebastian A Wagner
Werner Streicher
P2860
P2888
P304
P3181
P356
10.1038/NBT.3130
P50
P577
2015-03-09T00:00:00Z
P6179
1006421725